A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder

Acta Psychiatrica Scandinavica

Volumn 95, Issue 2, 1997, Pages 145-152

  Lecrubier, Y ^a   Bakker, A ^b   Dunbar, G ^c   Judge, R ^c  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Valeriuskliniek   (Netherlands)

^c GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Clomipramine; Panic attacks; Panic disorder; Paroxetine

Indexed keywords

CHLORAL HYDRATE; CLOMIPRAMINE; PAROXETINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG COMPARISON; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; MULTICENTER STUDY; NAUSEA; NEPHROLITHIASIS; PANIC; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SWEATING; TREMOR; VERTIGO; XEROSTOMIA;

EID: 0031049248     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1997.tb00388.x     Document Type: Article

References (26)

1. KLERMAN GL. Treatments for panic disorder. J Clin Psychiatry 1992: 53 (Suppl. 3): 14-19.
2. EVANS L, KENARDY J, SCHNEIDER P et al. Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks. Acta Psychiatr Scand 1986: 73: 49-53.
3. HOEHN-SARIC R, MCLEOD DR, HIPSLEY PA. Effect of fluvoxamine in panic disorder. J Clin Psychopharmacology 1993: 13: 321-326.
4. BLACK DW, WESNER R, BOWERS W et al. A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder. Arch Gen Psychiatry 1993: 50: 44-50.
5. FAWCETT J. Suicide risk factors in depressive disorders and in panic disorder. J Clin Psychiatry 1992: 53 (Suppl. 3): 9-13.
6. KLEIN DF. Delineation of two drug-responsive anxiety syndromes. Psychopharmacologia 1964: 5: 397-408.
7. GLOGER S, GRUNHAUS L, BIRMACHER B et al. Treatment of spontaneous panic attacks with clomipramine. Am J Psychiatry 1981: 138: 1215-1217.
8. BALLENGER JC. Pharmacotherapy of the panic disorders. J Clin Psychiatry 1986: 47 (Suppl. 6): 27-32.
9. CASSANO GB, PETRACCA A, PERUG G et al. Clomipramine for panic disorder. I. The first 10 weeks of a long-term comparison with imipramine. J Affect Dis 1988: 14: 123-127.
10. ZITRIN CM, KLEIN DF, WOERNER MG. Treatment of agoraphobia with group exposure in vivo and imipramine. Arch Gen Psychiatry 1980: 37: 63-72.
11. COOKSON J. Side-effects of antidepressants. Br J Psychiatry 1993: 163 (Suppl. 20): 20-24.
12. GLASSMAN AH, ROOSE SP. Risk of antidepressants in the elderly: tricyclic antidepressants and arrhythmia - revising risks. Gerontology 1994: 40 (Suppl. 1): 15-20.
13. SHEEHAN DV, BALLENGER JC, JACOBSEN G. Treatment of endogenous anxiety with phobic, hysterical and hypochondriacal symptoms. Arch Gen Psychiatry 1980: 37: 51-59.
14. ALEXANDER PE, ALEXANDER DD. Alprazolam treatment for panic disorders. J Clin Psychiatry 1986: 47: 301-304.
15. CHARNEY DS, HENINGER GR. Noradrenergic function and the mechanisms of action of antianxiety treatment. II. The effect of long-term imipramine treatment. Arch Gen Psychiatry 1985: 42: 473-481.
16. IVERSEN DS. 5-HT and anxiety. Neuropharmacology 1984: 23: 1553-1560.
17. WESTENBERG HGM, DEN BOER JA. Treatment of panic disorder: evidence supporting the role of serotonin. In: IDZIKOWSKI C, COWEN PJ, ed. Serotonin, sleep and mental disorders. Wrightson Biomedical Publishing Ltd, 1991: 147-160.
18. CHARNEY DS, WOODS SW, GOODMAN WK et al. Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects. Psychopharmacology 1987: 92: 14-24.
19. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC: American Psychiatric Association, 1987.
20. EATON WW, KESSLER RC, WITTCHEN HU et al. Panic and panic disorder in the United States. Am J Psychiatry 1994: 151: 413-420.
21. DEN BOER JA, WESTENBERG HGM, KAMBERBEEK J, VERHOEVEN WMA, KAHN RS. Effect of serotonin uptake inhibitors in anxiety disorders: a double-blind comparison of clomipramine and fluvoxamine. Int Clin Psychopharmacology 1987: 2: 21-32.
22. GORMAN JM, LIEBOWITZ MR, FYER AJ et al. An open trial of fluoxetine in the treatment of panic attacks (with published erratum in J Clin Psychopharmacology 1988: 8: 13). J Clin Psychopharmacology 1987: 7: 329-332.
23. HUMBLE M, KOCZKAS C, WISTEDT B. Serotonin and anxiety: an open study of citalopram in panic disorder. In: STEFANIS CN et al., ed. Psychiatry today. VIII World Congress of Psychiatry Abstracts. New York: Elsevier, 1989: 151.
24. SCHNEIER FR, LIEBOWITZ MR, DAVIES SO et al. Fluoxetine in panic disorder. J Clin Psychopharmacology 1990: 10: 119-121.
25. Cross-National Collaborative Panic Study, Second Phase Investigators. Comparative efficacy of alprazolam, imipramine, and placebo. Br J Psychiatry 1992: 160: 191-202.
26. DAGER SR, KHAN A, AVERY DH et al. Characteristics of placebo response during long-term treatment of panic disorder. Psychopharmacol Bull 1990: 26: 273-278.